{
    "URL": "https://doi.org/10.1371/journal.pntd.0010311",
    "Published": "March 31, 2022",
    "Subject_Areas": [
        "SARS CoV 2",
        "Virus testing",
        "Hybridomas",
        "COVID 19",
        "SARS coronavirus",
        "Enzyme-linked immunoassays",
        "Reverse transcriptase-polymerase chain reaction",
        "Nanoparticles"
    ],
    "Authors": {
        "Nol Salcedo": [
            "E25Bio, Inc., Cambridge, Massachusetts, United States of America"
        ],
        "Ankita Reddy": [
            "E25Bio, Inc., Cambridge, Massachusetts, United States of America",
            "Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America"
        ],
        "Adam R. Gomez": [
            "E25Bio, Inc., Cambridge, Massachusetts, United States of America"
        ],
        "Irene Bosch": [
            "Department of Medicine, Mount Sinai School of Medicine, New York, New York, United States of America",
            "Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America"
        ],
        "Bobby Brooke Herrera": [
            "E25Bio, Inc., Cambridge, Massachusetts, United States of America",
            "Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ]
    }
}